Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bridget Archambault"'
Autor:
Emily Hanzlik, Bridget Archambault, Mays El-Dairi, Kristin Schroeder, Mallika P. Patel, Eric S. Lipp, Katherine B. Peters, David M. Ashley, Daniel Landi
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:e464-e470
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e32a64cacd3b1a58217b6de58df2aab
https://doi.org/10.1097/mph.0000000000002598
https://doi.org/10.1097/mph.0000000000002598
Autor:
Kristin Schroeder, Mays Dairi, Katherine B. Peters, Eric S. Lipp, David M. Ashley, Daniel Landi, Mallika P Patel, Emily Hanzlik, Bridget Archambault, Song Boucree
Publikováno v:
Neuro-Oncology
Circumscribed low-grade gliomas comprise roughly one-third of pediatric CNS tumors. Most of these tumors are caused by activating mutations in the mitogen-activated protein kinase (MAPK) pathway. Drugs targeting the MAPK pathway are effective in othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0935a35d0a1f8fb3ecd6f3a65de6a6f4
http://europepmc.org/articles/PMC8168132
http://europepmc.org/articles/PMC8168132
Autor:
Eric Thompson, Daniel Landi, Gerald Archer, Eric Lipp, Ashley Walter, Bridget Archambault, Bea Balajonda, Charlene Flahiff, Denise Jaggers, James Herndon, Evan Buckley, Kristin Schroeder, Dina Randazzo, Annick Desjardins, Margaret Johnson, Katherine Peters, Mustafa Khasraw, Michael Malinzak, Duane Michell, David Ashley, John Sampson
Publikováno v:
Neuro-Oncology
Introduction The cytomegalovirus (CMV) antigen, pp65, is ubiquitously expressed in malignant glioma and medulloblastoma but not in healthy brain. The objective of this Phase I trial (NCT03299309) was to assess the safety and feasibility of a novel pp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae4c428db709fee1578749aa2ce7aa6
http://europepmc.org/articles/PMC8168240
http://europepmc.org/articles/PMC8168240
Autor:
James E. Herndon, Kristin Schroeder, Gary E. Archer, John Sampson, Charlene Flahiff, Denise Jaggers, Eric S. Lipp, Timothy A. Driscoll, Eric M. Thompson, Bridget Archambault, Daniel Landi, Patrick Healy, Luis Ramirez, Kathleen Hahn, David M. Ashley
Publikováno v:
Neuro-Oncology
BACKGROUND Recurrent medulloblastoma and malignant glioma are lethal tumors that are virtually incurable. The cytomegalovirus (CMV) antigen pp65 is ubiquitously expressed on medulloblastoma and malignant glioma but not on healthy brain. We evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a612711ffe4537da672afedadf7950
http://europepmc.org/articles/PMC7715746
http://europepmc.org/articles/PMC7715746
Autor:
John Sampson, James E. Herndon, Katherine B. Peters, Kristin Schroeder, Denise Jaggers, Eric S. Lipp, Gerald E. Archer, Duane Michell, Charlene Flahiff, Annick Desjardins, Ashley Walter, Bea Balajonda, Daniel Landi, Mustafa Khasraw, Bridget Archambault, Eric M. Thompson, Michael D. Malinzak, David M. Ashley, Evan Buckley, Margaret Johnson, Dina Randazzo
Publikováno v:
Neuro-Oncology
INTRODUCTION The cytomegalovirus (CMV) antigen, pp65, is ubiquitously expressed in malignant glioma and medulloblastoma but not in healthy brain. The objective of this Phase I trial (NCT03299309) was to assess the safety and feasibility of a novel pp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9770a8dba4bf8c65af7a5de14ad002f3
https://doi.org/10.1093/neuonc/noaa215.155
https://doi.org/10.1093/neuonc/noaa215.155
Publikováno v:
Neuro Oncol
Circumscribed low-grade glioma is generally driven by MAP kinase pathway activation, and this discovery motivates use of the non-competitive MEK 1/2 inhibitor trametinib for children and adults with progressive disease. However, rash is a common dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5301371af572e9b2b37c1a2c85e40082
https://doi.org/10.1093/neuonc/noz175.854
https://doi.org/10.1093/neuonc/noz175.854